SenesTech (SenesTech) ROCE % : -148.08% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is SenesTech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SenesTech's annualized ROCE % for the quarter that ended in Dec. 2023 was -148.08%.

SenesTech ROCE % Historical Data

The historical data trend for SenesTech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenesTech ROCE % Chart

SenesTech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-199.74

-183.38

-105.71

-122.29

-128.81

SenesTech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-192.62	-179.33	-243.83	-271.17	-148.08

SenesTech ROCE % Calculation

SenesTech's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-7.706	/	( ( (6.782 - 1.324)	+	(7.293 - 0.786) )	/ 2 )
	=	-7.706	/	( (5.458	+	6.507)	/ 2 )
	=	-7.706	/	5.9825
	=	-128.81 %

SenesTech's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-6.916	/	( ( (3.868 - 1.034)	+	(7.293 - 0.786) )	/ 2 )
	=	-6.916	/	( ( 2.834	+	6.507 )	/ 2 )
	=	-6.916	/	4.6705
	=	-148.08 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

SenesTech (NAS:SNES) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SenesTech ROCE % Related Terms

Thank you for viewing the detailed overview of SenesTech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

SenesTech (SenesTech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » SenesTech Inc (NAS:SNES) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

23460 N 19th Avenue, Suite 110, Phoenix, AZ, USA, 85027

Website

https://www.senestech.com

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets.

Executives

Joel Lee Fruendt	director, officer: Chief Executive Officer	C/O SENESTECH, INC., 23460 N. 19TH AVE., STE 110, PHOENIX AZ 85027
Grandinetti Phillip Nicholas Iii	director	23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Kathleen Claire Kavanagh	director	23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Jamie Bechtel Morrison	director	3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Jacob Steven Leach	director	6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Delphine Francois Chiavarini	director	3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Kenneth S Siegel	director, officer: Chief Executive Officer	40 STARWOOD HOTELS & RESORTS, 111 WESTCHESTER AVE, WHITE PLAINS NY 10604
Nicole C Williams	officer: Chief Strategy Officer	23460 N 19TH AVE SUITE 110, PHOENIX AZ 85027
Steven C. Krause	officer: EVP, Sales and Marketing	23460 N. 19TH AVE STE 110, PHOENIX AZ 85027
Loretta Powers Mayer	director, 10 percent owner, officer: CEO & Chief Scientific Officer	C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Cheryl Ann Dyer	director, 10 percent owner, officer: Pres. & Chief Research Officer	C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Edward Albe	officer: SVP of Commercialization	3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 96004
Julia Ann Williams	director	C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Andrew Altman	officer: Chief Operating Officer	C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Grover T Wickersham	director, officer: Vice Chairman	430 CAMBRIDGE AVENUE, SUITE 100, PALO ALTO CA 94306